Symbol: |
GFOD1
|
Description: |
glucose-fructose oxidoreductase domain containing 1 [Source:HGNC Symbol;Acc:21096]
|
Location: |
Chr6:13358062-13487787[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:226
Gene |
Compound |
Gen_sig |
Exp_pattern |
GFOD1 |
FCDR |
0.005 |
Up |
GFOD1 |
NSC 57958 |
0.046 |
Down |
GFOD1 |
9-AC |
0.023 |
Up |
GFOD1 |
Camptothecin ethylglycinate ester hydrochloride |
0.007 |
Up |
GFOD1 |
Camptothecin hemisuccinate sodium salt |
0.033 |
Up |
GFOD1 |
Camptothecin lysinate HCl |
0.026 |
Up |
GFOD1 |
NSC 611229 |
0.049 |
Down |
GFOD1 |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.014 |
Up |
GFOD1 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.038 |
Up |
GFOD1 |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.004 |
Down |
GFOD1 |
NSC 623925 |
0.026 |
Down |
GFOD1 |
Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- |
0.001 |
Down |
GFOD1 |
9-AMINO-20-CAMPTOTHECIN |
0.008 |
Up |
GFOD1 |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.014 |
Down |
GFOD1 |
NSC 632780 |
0.005 |
Down |
Expression pattern: Sensitivity / Resistance
Total:16 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:37
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|